Shrutika ****de lumikha ng bagong artikulo
1 sa - Isalin

Global Uterine Carcinosarcoma Market Advances with Growing Focus on Targeted Therapies and Precision Oncology | #uterine carcinosarcoma # uterine cancer # gynecologic oncology # cancer therapeutics # precision oncology # targeted therapy # immunotherapy # oncology drugs # cancer treatment # clinical trials # rare cancers # gynecologic cancer # personalized medicine # molecular diagnostics # cancer research

Global Uterine Carcinosarcoma Market Advances with Growing Focus on Targeted Therapies and Precision Oncology

The Uterine Carcinosarcoma Market was valued at USD 25.72 billion in 2025 and is projected to reach USD 42.56 billion by 2033, growing at a CAGR of 6.50% from 2026 to 2033